ArticleTherapeutic innovation & regulatory science2025

Statistical Considerations and Challenges with Time-to-Event Analyses for Composite Endpoints in Clinical Trials.

Kaiyi Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.